| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3188606 | Annales de Dermatologie et de Vénéréologie | 2010 | 5 Pages |
Abstract
The course of scleromyxoedema is unpredictable and treatment is extremely difficult. Successful therapy with IGIV has been reported but this approach seems to afford only temporary relief and maintenance infusions are required, as confirmed by the initial efficacy of treatment in our patient and the rapid recurrence of lesions following withdrawal.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
L. Sillard, T. Passeron, N. Cardot-Leccia, C. Perrin, J.-P. Lacour, J.-P. Ortonne,